Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Daily News

Drugs to Tweak RAAS Response No Help in Acute COVID-19, RCTs Show

Caitlin E. Cox

April 19, 2023

News Daily News

Flu Vaccines Reduce MACE, Especially in ACS: Meta-analysis

Yael L. Maxwell

May 06, 2022

News Conference News ISC 2022

Ischemic Stroke Risk Highest Early After COVID-19 Diagnosis

Todd Neale

February 17, 2022

News Daily News

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

Michael O'Riordan

April 02, 2021

News Opinion CV Team Dispatch

January 2021 News Roundup

L.A. McKeown

January 01, 2021

News Daily News

Obesity’s Role in COVID-19 Deaths: Big Food, Slow Government to Blame?

Shelley Wood

June 11, 2020

News Features

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

Caitlin E. Cox

April 23, 2020

News Daily News

New Wuhan Data Confirm High Hypertension Rate in COVID-19 Deaths

Todd Neale

April 10, 2020

News Daily News

ACE Inhibitors, ARBs, and COVID-19: New Insights, Advice

Yael L. Maxwell

March 26, 2020

News Daily News

Time for Guidelines to Recommend ARBs Over ACE Inhibitors?

Shelley Wood

March 29, 2018

News Daily News

Medicare Part D Has Scant Effect on Outcomes for Acute MI Patients

Yael L. Maxwell

November 04, 2015

News Daily News

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

Caitlin E. Cox

October 27, 2015

News Industry News

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

June 19, 2015

Advertisement

Drugs to Tweak RAAS Response No Help in Acute COVID-19, RCTs Show

Flu Vaccines Reduce MACE, Especially in ACS: Meta-analysis

Ischemic Stroke Risk Highest Early After COVID-19 Diagnosis

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

January 2021 News Roundup

Obesity’s Role in COVID-19 Deaths: Big Food, Slow Government to Blame?

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

New Wuhan Data Confirm High Hypertension Rate in COVID-19 Deaths

ACE Inhibitors, ARBs, and COVID-19: New Insights, Advice

Time for Guidelines to Recommend ARBs Over ACE Inhibitors?

Medicare Part D Has Scant Effect on Outcomes for Acute MI Patients

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content